GlassScriptPhysician profile
Annette Hall
NPI 1235763012
$3,343.17
in general payments reported to CMS, 2019-2025
22 companies · $1,559 in 2025
The $1,559 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $281 · 2023: $360 · 2024: $1,142 · 2025: $1,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,651 · Education: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,650.59 |
| Education | $411.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,016.30 | 2022-2025 | Breztri, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $533.94 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Jazz Pharmaceuticals INC. | $460.63 | 2022-2025 | |
| Genzyme Corporation | $362.72 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $194.90 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $136.72 | 2024-2025 | Dupixent |
| Insmed, INC. | $102.98 | 2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $83.59 | 2022-2025 | Glassia |
| Mylan Specialty L.P. | $79.25 | 2022-2024 | Yupelri |
| Grifols USA, LLC | $65.91 | 2024-2025 | Prolastin-C Liquid |
| Verona Pharma, INC. | $59.91 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $50.68 | 2025 | Yupelri |
| Lilly USA, LLC | $39.76 | 2025 | Zepbound |
| Abbvie INC. | $24.92 | 2025 | |
| United Therapeutics Corporation | $22.97 | 2025 | Tyvaso |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $18.33 | 2023 | Fetroja |
| Vifor Pharma, INC. | $17.54 | 2025 | Zemaira |
| Pulmonx Corporation | $16.77 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Baxter Healthcare | $14.70 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $14.40 | 2024 | (Ak6) Vest Therapy |
| Axsome Therapeutics, INC. | $13.29 | 2023 | Sunosi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.96 | 2023 | Ofev |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annette Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.